Global leaders in life sciences and nonclinical drug development, Envigo (Huntingdon, UK) and LabCorp (NC, USA), have signed an innovative agreement in a bid to expand nonclinical drug development capabilities and create an independent research models provider.
Charles River Laboratories have signed an agreement to acquire Citoxlab for $510 million in a deal that aims to expand their global scale and scientific service portfolio.
Bristol-Myers Squibb (NY, USA) have announced that they will be acquiring Celgene (NJ, USA) this year for a cost of $74 billion.
Webinar available to view on demand. Exploring the challenges a lack of industry standardization presents for CRO project managers and scientists as well as biopharma and biotech companies.
Find out what Naidong Weng (Janssen Research and Development) has to say about the future of bioanalytical outsourcing, in this expert interview.
Find out what Marco Michi (Aptuit) has to say about the future of bioanalytical outsourcing, in this expert interview.
Find out what Kevin Vernarec (QPS) thinks about how outsourcing might change in the future in this expert interview.
Find out what Song Li (Frontage) has to say about the future of bioanalytical outsourcing, in this video interview.
The Good Clinical Laboratory Practice accreditation will enable the company to extend its proteomic services to the analysis of clinical trial samples.
Lonza (Basel, Switzerland) announce the launch of four new services to expand their early phase biopharmaceutical drug development.